Harbor Advisory Corp MA Sells 1,420 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Harbor Advisory Corp MA lowered its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.5% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 30,105 shares of the exchange traded fund’s stock after selling 1,420 shares during the period. Harbor Advisory Corp MA’s holdings in SPDR S&P Biotech ETF were worth $2,711,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Golden State Wealth Management LLC purchased a new position in SPDR S&P Biotech ETF during the fourth quarter valued at $29,000. Avior Wealth Management LLC raised its stake in SPDR S&P Biotech ETF by 393.6% during the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after buying an additional 307 shares during the last quarter. Tidemark LLC raised its stake in SPDR S&P Biotech ETF by 101.5% during the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after buying an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. purchased a new position in SPDR S&P Biotech ETF during the third quarter valued at $40,000. Finally, ORG Wealth Partners LLC purchased a new position in SPDR S&P Biotech ETF during the third quarter valued at $44,000.

SPDR S&P Biotech ETF Trading Down 1.4 %

Shares of NYSEARCA:XBI opened at $89.05 on Wednesday. The stock has a fifty day simple moving average of $92.23 and a two-hundred day simple moving average of $96.30. The stock has a market capitalization of $6.79 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.